Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
Small molecules targeting fibroblast activation protein (FAP) have emerged as a new group of tracers for positron emission tomography (PET) in 2018. While most of the existing literature has been focussed on the application of FAP-specific PET in various kinds of cancers, some researchers have, both...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 February 2021
|
| In: |
EJNMMI Research
Year: 2021, Jahrgang: 11, Pages: 1-12 |
| ISSN: | 2191-219X |
| DOI: | 10.1186/s13550-021-00761-2 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13550-021-00761-2
|
| Verfasserangaben: | Paul Windisch, Daniel R. Zwahlen, Frederik L. Giesel, Eberhard Scholz, Patrick Lugenbiel, Jürgen Debus, Uwe Haberkorn and Sebastian Adeberg |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1753291119 | ||
| 003 | DE-627 | ||
| 005 | 20230426165449.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210407s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13550-021-00761-2 |2 doi | |
| 035 | |a (DE-627)1753291119 | ||
| 035 | |a (DE-599)KXP1753291119 | ||
| 035 | |a (OCoLC)1341403726 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Windisch, Paul |d 1993- |e VerfasserIn |0 (DE-588)1139145029 |0 (DE-627)897186486 |0 (DE-576)49295870X |4 aut | |
| 245 | 1 | 0 | |a Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications |b systematic review |c Paul Windisch, Daniel R. Zwahlen, Frederik L. Giesel, Eberhard Scholz, Patrick Lugenbiel, Jürgen Debus, Uwe Haberkorn and Sebastian Adeberg |
| 264 | 1 | |c 19 February 2021 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.04.2021 | ||
| 520 | |a Small molecules targeting fibroblast activation protein (FAP) have emerged as a new group of tracers for positron emission tomography (PET) in 2018. While most of the existing literature has been focussed on the application of FAP-specific PET in various kinds of cancers, some researchers have, both intentionally or unintentionally, used FAP-specific PET in patients with non-cancerous diseases. The purpose of this systematic review is therefore to summarize the available evidence of FAP-specific PET for non-malignant indications. | ||
| 650 | 4 | |a FAP | |
| 650 | 4 | |a Fibroblast activation protein | |
| 650 | 4 | |a Fibroblasts | |
| 650 | 4 | |a PET | |
| 650 | 4 | |a PET-CT | |
| 650 | 4 | |a Positron emission tomography | |
| 700 | 1 | |a Zwahlen, Daniel R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Giesel, Frederik L. |d 1970- |e VerfasserIn |0 (DE-588)129031240 |0 (DE-627)387883878 |0 (DE-576)297457071 |4 aut | |
| 700 | 1 | |a Scholz, Eberhard P. |d 1978- |e VerfasserIn |0 (DE-588)13163660X |0 (DE-627)512033994 |0 (DE-576)298640589 |4 aut | |
| 700 | 1 | |a Lugenbiel, Patrick |d 1982- |e VerfasserIn |0 (DE-588)137855710 |0 (DE-627)696120062 |0 (DE-576)305349414 |4 aut | |
| 700 | 1 | |a Debus, Jürgen |d 1964- |e VerfasserIn |0 (DE-588)1022671421 |0 (DE-627)717025780 |0 (DE-576)365774944 |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 700 | 1 | |a Adeberg, Sebastian |d 1984- |e VerfasserIn |0 (DE-588)1049743377 |0 (DE-627)782574467 |0 (DE-576)403727774 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t EJNMMI Research |d Berlin : Springer, 2011 |g 11(2021), Artikel-ID 18, Seite 1-12 |h Online-Ressource |w (DE-627)664970265 |w (DE-600)2619892-7 |w (DE-576)347917895 |x 2191-219X |7 nnas |a Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications systematic review |
| 773 | 1 | 8 | |g volume:11 |g year:2021 |g elocationid:18 |g pages:1-12 |g extent:12 |a Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications systematic review |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s13550-021-00761-2 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210407 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1049743377 |a Adeberg, Sebastian |m 1049743377:Adeberg, Sebastian |d 910000 |d 911400 |d 50000 |e 910000PA1049743377 |e 911400PA1049743377 |e 50000PA1049743377 |k 0/910000/ |k 1/910000/911400/ |k 0/50000/ |p 8 |y j | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 7 | ||
| 998 | |g 1022671421 |a Debus, Jürgen |m 1022671421:Debus, Jürgen |d 910000 |d 911400 |e 910000PD1022671421 |e 911400PD1022671421 |k 0/910000/ |k 1/910000/911400/ |p 6 | ||
| 998 | |g 137855710 |a Lugenbiel, Patrick |m 137855710:Lugenbiel, Patrick |d 910000 |d 910100 |d 50000 |e 910000PL137855710 |e 910100PL137855710 |e 50000PL137855710 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 5 | ||
| 998 | |g 13163660X |a Scholz, Eberhard P. |m 13163660X:Scholz, Eberhard P. |d 50000 |e 50000PS13163660X |k 0/50000/ |p 4 | ||
| 998 | |g 129031240 |a Giesel, Frederik L. |m 129031240:Giesel, Frederik L. |d 910000 |d 911400 |e 910000PG129031240 |e 911400PG129031240 |k 0/910000/ |k 1/910000/911400/ |p 3 | ||
| 999 | |a KXP-PPN1753291119 |e 3903161136 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1186/s13550-021-00761-2"],"eki":["1753291119"]},"name":{"displayForm":["Paul Windisch, Daniel R. Zwahlen, Frederik L. Giesel, Eberhard Scholz, Patrick Lugenbiel, Jürgen Debus, Uwe Haberkorn and Sebastian Adeberg"]},"recId":"1753291119","physDesc":[{"extent":"12 S."}],"title":[{"subtitle":"systematic review","title":"Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications","title_sort":"Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 07.04.2021"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"19 February 2021"}],"relHost":[{"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisher":"Springer"}],"pubHistory":["1.2011 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 29.10.13"],"id":{"issn":["2191-219X"],"eki":["664970265"],"zdb":["2619892-7"]},"part":{"year":"2021","pages":"1-12","extent":"12","text":"11(2021), Artikel-ID 18, Seite 1-12","volume":"11"},"title":[{"title_sort":"EJNMMI Research","title":"EJNMMI Research"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"664970265","disp":"Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications systematic reviewEJNMMI Research"}],"person":[{"display":"Windisch, Paul","family":"Windisch","role":"aut","given":"Paul"},{"display":"Zwahlen, Daniel R.","family":"Zwahlen","role":"aut","given":"Daniel R."},{"display":"Giesel, Frederik L.","family":"Giesel","given":"Frederik L.","role":"aut"},{"family":"Scholz","role":"aut","given":"Eberhard P.","display":"Scholz, Eberhard P."},{"family":"Lugenbiel","given":"Patrick","role":"aut","display":"Lugenbiel, Patrick"},{"display":"Debus, Jürgen","role":"aut","given":"Jürgen","family":"Debus"},{"family":"Haberkorn","given":"Uwe","role":"aut","display":"Haberkorn, Uwe"},{"role":"aut","given":"Sebastian","family":"Adeberg","display":"Adeberg, Sebastian"}]} | ||
| SRT | |a WINDISCHPACLINICALRE1920 | ||